Testimonial by Dr. Olga Popovska!

Dr. Olga Popovska

Institute of Organic Technology, Faculty of Technology and Metallurgy,

Ss. Cyril and Methodius University, Rudjer Boskovic 16, 1000,

Skopje, Republic of Macedonia

Contributed Article: “A RP-HPLC Method for the Determination of Ketoconazole in Pharmaceutical Dosage Forms”

New Issue ::: Current Medicinal Chemistry, 23 Issue 23

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Articles from the journal Current Medicinal Chemistry, 23 Issue 23:

• Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones
• From Bone Marrow to Cardiac Atrial Appendage Stem Cells for Cardiac Repair: A Review
• The Use of Stilbene Scaffold in Medicinal Chemistry and Multi- Target Drug Design
• Nanomedicine for Intra-Articular Drug Delivery in Rheumatoid Arthritis
• Current Progresses and Trends in the Development of Progesterone Receptor Modulators

For details on the articles, please visit this link :: http://bit.ly/2bNbvVf

New Issue ::: Current Alzheimer Research, 13 Issue 10

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease.

Articles from the journal Current Alzheimer Research, Volume 13 Issue 10:

• Neuropsychiatric Disturbances in Mild Cognitive Impairment (MCI): A Systematic Review of Population-Based Studies
• Suicide Risk in Alzheimer’s Disease: A Systematic Review
• Psychological Interventions for Neuropsychiatric Disturbances in Mild and Moderate Alzheimer’s Disease: Current Evidences and Future Directions
• Physical Exercise for the Treatment of Neuropsychiatric Disturbances in Alzheimer’s Dementia: Possible Mechanisms, Current Evidence and Future Directions
• The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks
• Pharmacological Management of Agitation and Aggression in Alzheimer’s Disease: A Review of Current and Novel Treatments
• Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
• Alzheimer’s Disease is Associated with Increased Risk of Osteoporosis: The Chongqing Aging Study
• Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer’s Disease
• The Brainstem Tau Cytoskeletal Pathology of Alzheimer’s Disease: A Brief Historical Overview and Description of its Anatomical Distribution Pattern, Evolutional Features, Pathogenetic and Clinical Relevance

For details on the articles, please visit this link :: http://bit.ly/2bNrjaP

Testimonial by Dr. Yousef Alqasrawi!

Dr. Yousef Alqasrawi

Assistant Professor of Computer Science Head,

Computer Information Systems (CIS) Faculty of Information Technology,

Applied Science University PO BOX 166 Amman 11931 Jordan

Contributed Article: “Natural Scene Image Annotation Using Local Semantic Concepts and Spatial Bag of Visual Words”

Upcoming Thematic Issue – Cardiovascular Prevention: Can We Do Any Better

http://benthamscience.com/journals/current-pharmaceutical-design/

SMI EVENT – 9th annual Social Media in the Pharmaceutical Industry conference!

SMi is proud to present the return of their 9th annual Social Media in the Pharmaceutical Industry conference to London from 18th January – 19th January 2017.

Gathering a unique audience of senior industry innovators in healthcare and digital marketing including AbbVie, Accenture, Creation, MHRA, MSD, GE Healthcare, Janssen, Lundbeck, and Pfizer, SMi Group’s sell-out show Social Media in the Pharmaceutical Industry returns to London on 18-19 January 2017.

The two-day conference will provide a platform for senior marketing practitioners to capture the latest trends and technologies, learn from practical case studies and benchmark best practice to maximise digital strategy. Day 1 will address topics on social listening skills for adapting to patient requirements, digital strategy, patient engagement, and creating content to leverage your branding; whilst Day 2 will explore advancements in technology including mHealth apps and their effect on the industry, regulatory updates and social networking for HCPs.

Featured speakers include:

• Daniel Ghinn, Founder & CEO, Creation Healthcare
• Julie O’Donnell, Head of Global Customer Interaction Management, Lundbeck
• Phil Tregunno, Signal Management Unit Manager, WEB-RADR Project Lead, MHRA
• Thibaud Guymard, Head of Digital Services, MSD
• Doris Casares, Communications Director, Medicines for Europe
• Scott Gavin, Regional Lead, Digital Centre of Excellence / Digital Services, Pfizer
• Dimithri Wignarajah, Head of Content & Social Media, GE Healthcare Life Sciences

..and more!

The event will also feature two pre-conference workshops hosted by Stinesorensen Lundbeck and the Conversationalist Agency.

Register at www.social-media-pharma.com/bentham

New Issue ::: Current Neuropharmacology, 14 Issue 7

Current Neuropharmacology aims to provide current, timely and comprehensive reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.

The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Articles from the journal Current Neuropharmacology , Volume 14 Issue 7:

• Editorial (Thematic Selection: Inflammatory and Immune Responses in Depression)
• Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
• Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
• Animal Models of Maternal Immune Activation in Depression Research
• A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
• Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
• Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
• Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem
• Systems Genomics Support for Immune and Inflammation Hypothesis of Depression
• Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models
• Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol

For details on the articles, please visit this link :: http://bit.ly/2csqKVy

New Issues of various Bentham Science Journals!

Letters in Drug Design & Discovery, 13 Issue 8

http://bit.ly/2cm6zbE

Current Nanoscience, 12 Issue 5

http://bit.ly/2cdHbrf

Recent Patents on Mechanical Engineering, 9 Issue 3

http://bit.ly/2bXWqm3

Current Medicinal Chemistry, 23 Issue 24

http://bit.ly/2bQzitO

Current Stem Cell Research & Therapy, 11 Issue 7

http://bit.ly/2bRrdlz

Testimonial by Dr. R. K. Bansal!

Dr. R. K. Bansal

Department of Chemistry, The IIS University,

Mansarovar, Jaipur-302020, India

Contributed Article: “Analogy of Phosphaalkenes and Azaphospholes with their Respective non-phosphorus analogues”